Efficacy and Safety of Lisdexamfetamine Dimesylate in Children with Attention-Deficit/Hyperactivity Disorder and Recent Methylphenidate Use

INTRODUCTION: Lisdexamfetamine dimesylate (LDX) is a long-acting prodrug stimulant for the treatment of attention-deficit/hyperactivity disorder (ADHD). Post hoc subgroup analyses were performed from two studies in children with ADHD to compare the efficacy of LDX in participants who had received pr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jain, Rakesh, Babcock, Thomas, Burtea, Teodor, Dirks, Bryan, Adeyi, Ben, Scheckner, Brian, Lasser, Robert, Renna, John, Duncan, Don
Formato: Artigo
Lenguaje:Inglês
Publicado: Springer Healthcare 2013
Materias:
Original Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3680667/
https://ncbi.nlm.nih.gov/pubmed/23681505
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-013-0027-2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares